Four eye ointments are being voluntarily recalled after a Food and Drug Administration (FDA) inspection noted a “lack of sterility assurance” at the facility where the products were held. The FDA on Monday published the Brassica Pharma Pvt. Ltd. company announcement from Feb. 12, which warned patients that “there is a potential risk of eye…
"Brassica Pharma recalls eye ointment products due to sterility concerns. Patients at risk of eye infections. Other eye product recalls in the past year."